SCYNEXIS Inc (SCYX) stock
SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.82−0.03 (-1.05%)
Close on Nov 18, 2026Market cap $28.06MP/E –Yield –
Scynexis market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Scynexis's market cap was $33.98M on Nov 11, 2026, against $28.95M a year earlier. Over the last 5 years it ranged from $25.86M to $145.70M, with a median of $55.27M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $33.98M | +28.1% |
| 2025 | Dec 31, 2025 | $26.53M | -42.2% |
| 2024 | Dec 31, 2024 | $45.91M | -44.6% |
| 2023 | Dec 29, 2023 | $82.90M | +62.7% |
| 2022 | Dec 30, 2022 | $50.94M | -65.0% |
| 2021 | Dec 31, 2021 | $145.70M | +76.4% |
| 2020 | Dec 31, 2020 | $82.61M | +58.2% |
| 2019 | Dec 31, 2019 | $52.20M | +129.6% |
| 2018 | Dec 31, 2018 | $22.73M | -65.4% |
| 2017 | Dec 29, 2017 | $65.74M | -12.0% |
| 2016 | Dec 30, 2016 | $74.74M | -13.4% |
| 2015 | Dec 31, 2015 | $86.35M | +1.7% |
| 2014 | Dec 31, 2014 | $84.95M | – |
See a number that looks wrong?